Omar Ishrak retires after 9 years as Medtronic CEO: 6 things to know about his replacement

Alan Condon -   Print  |

Omar Ishrak on April 26 retired as Medtronic CEO and transitioned to executive chairman, after a nine-year stint as head of the medical device company.

Six things to know:

1. Geoff Martha, who has been with Medtronic for nine years, assumed the position of CEO on April 27. From November through April, he served as president of the company, and joined the board of directors in November.

2. Mr. Martha previously served as senior vice president of strategy and business development, leading Medtronic's $10 billion acquisition of Covidien in 2015.

3. As executive vice president of the restorative therapies group, Mr. Martha was responsible for RTG's four divisions — spine, brain therapies, specialty therapies and pain therapies. Under his leadership, RTG achieved a record of $8 billion in revenue for the 2019 fiscal year.

4. Before joining Medtronic, Mr. Martha was managing director of business development at GE Healthcare, and held several other executive roles during his 19 years at the company.

5. He is a member of the Medtronic Foundation board of directors and acts as executive sponsor of First Robotics, an annual international high school robotics competition.

6. Mr. Martha will be tasked with leading the company through the COVID-19 pandemic, continuing Medtronic's investment in robotic technologies and identifying opportunities for future growth.

More articles on devices:
AAOS publishes clinical considerations for return to elective surgery
97% of medical practices suffer COVID-19 financial hit: 5 observations for orthopedics
Investor pays $49M for Arizona spine, orthopedic hospital property

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers